SEC Info - Goldman Sachs Group Inc, et al. - ‘SC 13D/A’ on 11/7/96 re: Quorum Health Group Inc

SEC Info℠

Home

Help

Please Sign In

Goldman Sachs Group Inc, et al. – ‘SC 13D/A’ on 11/7/96 re: Quorum Health Group Inc

As of: Thursday, 11/7/96 · Accession #: 950130-96-4227 · File #: 5-43277

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/07/96  Goldman Sachs Group Inc           SC 13D/A               1:28K  Quorum Health Group Inc           Donnelley R R & S… 02/FA
          Goldman Sachs Group LP
          Goldman, Sachs & Co.
          GS Advisors, L.P.
          GS Capital Partners, L.P.

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment # 6 to Schedule 13-D                        17     51K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Gs Advisors, L.P Identity and Background Interest in Securities of the Issuer Is Hereby Amended as Follows: Purpose of the Transaction Schedule 13D Source and Amount of Funds or Other Consideration
1	1st Page - Filing Submission
"	Schedule 13D
3	Gs Advisors, L.P
6	Item 2. Is Hereby Amended as Follows:
"	Item 2. Identity and Background
7	Item 3. Source and Amount of Funds or Other Consideration
"	Item 4. Purpose of the Transaction
8	Item 5. Interest in Securities of the Issuer

SC 13D/A 1st Page of 17 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549  

SCHEDULE 13D  
UNDER THE SECURITIES EXCHANGE ACT OF 1934 
(AMENDMENT NO. 6) 

Quorum Health Group, Inc  
------------------------------------------------------------------- 
(Name of Issuer)  

Common Stock, par value $.01 per share  
--------------------------------------------------------------------------------
(Title of Class of Securities)  

749084109 
----------------------------------------------------- 
(CUSIP Number)  

David J. Greenwald, Esq.  
Goldman, Sachs & Co.  
85 Broad Street 
New York, New York 10004  
(212) 902-1000  
--------------------------------------------  
(Name, address and telephone number of person authorized  
to receive notices and communications)  

October 29, 1996  
--------------------------------------------------------------------------------
(Date of Event which requires Filing of this Statement) 

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this   
schedule because of Rule 13d-1(b) (3) or (4), check the following box:  _____   

Check the following box if a fee is being paid with this statement: ____        

Page 1

SC 13D/A 2nd Page of 17 TOC 1st Previous Next ↓Bottom Just 2nd
-----------------                                                               
CUSIP NO.                                                                       
749084109                                                                       
----------                                                                      
--------------------------------------------------------------------------------
1.  Name of Reporting Person                                                    
S.S. or  I.R.S. Identification No. of  Above Person                     

GS Capital Partners, L.P.                                               
--------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                            

                                             (a) _____
                                             (b) _____
--------------------------------------------------------------------------------
3.  SEC Use Only                                                                

--------------------------------------------------------------------------------
4.  Source of Funds                                                             

--------------------------------------------------------------------------------
5.  Check Box if Disclosure of Legal Proceedings is Required                    
Pursuant to Items 2(d) or 2(e)                                          

--------------------------------------------------------------------------------
6.  Citizenship or place of Organization                                        

Delaware                                                            
--------------------------------------------------------------------------------
Number of       7  Sole Voting Power                                            
Shares                                                                          
Beneficially             -0-                                                    
-------------------------                       
Owned By        8  Shared Voting Power                                          
Each                                                                            
Reporting               11,712                                                  
-------------------------                       
Person With     9  Sole Dispositive Power                                       

-0-                           
-------------------------                       

10 Shared Dispositive Power                     

11,712                          
-------------------------                       
11.  Aggregate Amount Beneficially Owned by Each Reporting Person               

11,712                                      
--------------------------------------------------------------------------------
12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares          
                                                      /    /
                                                     -------
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)                         

0.0%                                  
--------------------------------------------------------------------------------
14.  Type of Reporting Person                                                   

PN                                    
--------------------------------------------------------------------------------

Page 2

SC 13D/A 3rd Page of 17 TOC 1st Previous Next ↓Bottom Just 3rd
----------------------                                                          
CUSIP NO.                                                                       
749084109                                                                     
-----------                                                                     
--------------------------------------------------------------------------------
1.  Name of Reporting Person                                                    
S.S. or I.R.S. Identification No. of Above Person                     

GS  Advisors, L.P.                                                    
--------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                            

                                   (a) _____
                                   (b) _____
--------------------------------------------------------------------------------
3.  SEC Use Only                                                                

--------------------------------------------------------------------------------
4.  Source of Funds                                                             

--------------------------------------------------------------------------------
5.  Check Box if Disclosure of Legal Proceedings is Required                    
Pursuant to Items 2(d) or 2(e)                                        

--------------------------------------------------------------------------------
6.  Citizenship or place of Organization                                        

Delaware                                                                        
-----------------------------------------                                       
Number of       7  Sole Voting Power                                            
Shares                                                                          
Beneficially               -0-                                                  
----------------------                    
Owned By        8  Shared Voting Power                                          
Each                                                                            
Reporting                 11,712                                                
----------------------                    
Person With     9  Sole Dispositive Power                                       

-0-                       
----------------------                    
10  Shared Dispositive Power                      

11,712                      
----------------------                    
11.  Aggregate Amount Beneficially Owned by Each Reporting Person               

11,712                                                        
--------------------------------------------------------------------------------
12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares          
                                                           /     /
                                                          ------
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)                         

0.0%                                                          
--------------------------------------------------------------------------------
14.  Type of Reporting Person                                                   

PN                                                          
--------------------------------------------------------------------------------

Page 3

SC 13D/A 4th Page of 17 TOC 1st Previous Next ↓Bottom Just 4th
------------------------                                                        
CUSIP NO.                                                                       
749084109                                                                       
----------                                                                      
--------------------------------------------------------------------------------
1.  Name of Reporting Person                                                    
S.S. or  I.R.S. Identification No. of  Above Person                   

Goldman, Sachs & Co.                                                  
--------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                            

                                   (a) _____
                                   (b) _____
--------------------------------------------------------------------------------
3.  SEC Use Only                                                                

--------------------------------------------------------------------------------
4.  Source of Funds                                                             

--------------------------------------------------------------------------------
5.  Check Box if Disclosure of Legal Proceedings is Required                    
Pursuant to Items 2(d) or 2(e)                                        

--------------------------------------------------------------------------------
6.  Citizenship or place of Organization                                        

New York                                                                        
-----------------------------------------                                       

Number of       7  Sole Voting Power                                            
Shares                                                                          
Beneficially             -0-                                                    
----------------------                    
Owned By        8  Shared Voting Power                                          
Each                                                                            
Reporting           2,249,073                                                   
----------------------                    
Person With     9  Sole Dispositive Power                                       

-0-                         
----------------------                    
10  Shared Dispositive Power                      
2,249,073                               
--------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person               
2,249,073                               
--------------------------------------------------------------------------------
12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares          
                                                  /    /
                                                 -------
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)                         

4.6%                                                                
--------------------------------------------------------------------------------
14.  Type of Reporting Person                                                   

BD-PN                                                               
--------------------------------------------------------------------------------

Page 4

SC 13D/A 5th Page of 17 TOC 1st Previous Next ↓Bottom Just 5th
----------------------                                                          
CUSIP NO.                                                                       
749084109                                                                     
-----------                                                                     
--------------------------------------------------------------------------------
1.  Name of Reporting Person                                                    
S.S. or I.R.S. Identification No. of Above Person                     

The Goldman Sachs Group, L.P.                                         
--------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                            

                                                   (a) _____
                                                   (b) _____
--------------------------------------------------------------------------------
3.  SEC Use Only                                                                

--------------------------------------------------------------------------------
4.  Source of Funds                                                             

--------------------------------------------------------------------------------
5.  Check Box if Disclosure of Legal Proceedings is Required                    
Pursuant to Items 2(d) or 2(e)                                        

--------------------------------------------------------------------------------
6.  Citizenship or place of Organization                                        

Delaware                                                                        
-----------------------------------------                                       

Number of       7  Sole Voting Power                                            
Shares                                                                          
Beneficially       1,228,315                                                    
------------------------------                  
Owned By        8  Shared Voting Power                                          
Each                                                                            
Reporting          2,249,073                                                    
------------------------------                  
Person With     9  Sole Dispositive Power                                       
1,228,315                                 
------------------------------                  
10  Shared Dispositive Power                      
2,249,073                                 
--------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person               
3,477,388                                 
--------------------------------------------------------------------------------
12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares          
                                                                 /     /
                                                                ------
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)                         

7.1%                                                              
--------------------------------------------------------------------------------
14.  Type of Reporting Person                                                   

HC-PN                                                             
--------------------------------------------------------------------------------

Page 5

SC 13D/A 6th Page of 17 TOC 1st Previous Next ↓Bottom Just 6th
AMENDMENT NO. 6 TO
SCHEDULE 13D
RELATING TO THE COMMON STOCK OF 
QUORUM HEALTH GROUP, INC. 

GS Capital Partners, L.P. ("GSCP"), GS Advisors, L.P. ("GS Advisors,  
L.P."), Goldman, Sachs & Co. ("Goldman Sachs") and The Goldman Sachs Group, L.P.
("GS Group" and together with GSCP, GS Advisors, L.P. and Goldman Sachs, the    
"Filing Persons")/*/ hereby amend the statement on Schedule 13D filed with      
respect to the common stock, par value $.01 per share (the "Common Stock"), of  
Quorum Health Group, Inc., a Delaware corporation (the "Company"), as most      
recently amended by Amendment No. 5 thereto dated October 30, 1996 (as amended, 
the "Schedule 13D"). Unless otherwise indicated, all capitalized terms used but 
not defined herein shall have the same meaning ascribed to them in the Schedule 
13D.                                                                            

This Amendment No. 6 is being filed to change the description of the  
Distribution described in Amendment No. 5 to reflect that GSCP distributed to   
its partners on a pro rata basis in accordance with its partnership agreement   
2,916,204 shares owned by GSCP, and after the Distribution, GSCP owned 46 Shares
of Common Stock.                                                                

Item 2 is hereby amended as follows:                                  

Item 2.  Identity and Background.                                     
-----------------------                             

 GS Group and Goldman Sachs may be deemed, for purposes of this Schedule
13D, to own beneficially 2,249,073 shares of Common Stock, including (i) shares 
of Common Stock owned by certain limited partnerships (the "Other Limited       
Partnerships") of which affiliates of Goldman Sachs and GS Group are the general
partner or the managing general partner, (ii) shares of Common Stock held by    
Goldman Sachs in connection with its ordinary course trading activities, (iii)  
shares of Common Stock currently held in managed accounts (the "Managed         
Accounts") for which Goldman Sachs exercises voting and/or investment authority,
and (iv) shares of Common Stock owned by GSCP and shares of Common Stock that   
may be purchased pursuant to options beneficially owned by GSCP that are        
currently exercisable or that may be exercised within 60 days (as described in  
Item 5                                                                          

--------------------------                                                      
/*/ Neither the present filing nor anything contained herein shall be construed 
as an admission that Goldman Sachs, GS Group or any of the partnerships 
constitute a "person" for any purpose other than Section 13(d) of the   
Securities Exchange Act of 1934.                                        

SC 13D/A 7th Page of 17 TOC 1st Previous Next ↓Bottom Just 7th
below). In addition, GS Group beneficially owns 1,228,315 shares of Common      
Stock, including the shares of Common Stock received by it in connection with   
the Distribution described in Item 4 below and shares of Common Stock that may  
be purchased pursuant to options beneficially owned by GS Group that are        
currently exercisable (as described in Item 5 below). Goldman Sachs and GS Group
each disclaims beneficial ownership of shares of Common Stock (i) owned by the  
Other Limited Partnerships and GSCP to the extent of partnership interests in   
the Other Limited Partnerships and GSCP held by persons other than Goldman      
Sachs, GS Group or their affiliates and (ii) held in Managed Accounts.          

Item 3 is hereby amended as follows:                                  

Item 3.  Source and Amount of Funds or Other Consideration.           
-------------------------------------------------   

     See Schedule IV hereto for transactions in the Common Stock which have been
effected since October 29, 1996, the date through which transactions were       
disclosed in Amendment No. 5 to this Schedule 13D. The total consideration      
(exclusive of commissions) for shares of Common Stock purchased since October   
29, 1996 is $9,700,098. All such transactions were effected in the ordinary     
course of business of Goldman Sachs. Funds for the purchases made in ordinary   
course trading activities by Goldman Sachs came from working capital. Funds for 
the purchase of shares of Common Stock held in Managed Accounts came from client
funds. No consideration was paid by any distributee in connection with the      
Distribution described in Item 4 below.                                         

Item 4 is hereby amended as follows:                                  

Item 4.  Purpose of the Transaction.                                  
--------------------------                          

     On October 29, 1996, GSCP distributed (the "Distribution") 2,916,204 shares
of Common Stock owned by GSCP to its partners on a pro rata basis in accordance 
                              --- ----
with GSCP's partnership agreement. The shares distributed to the partners (other
than the partners, if any, who are                                              

SC 13D/A 8th Page of 17 TOC 1st Previous Next ↓Bottom Just 8th
"affiliates" of the Company (as such term is defined under the Securities Act)) 
are salable without registration under the Securities Act and without regard to 
the requirements of Rule 144 under the Securities Act, and the shares           
distributed to any partner which is an affiliate of the Company are salable     
pursuant to Rule 144. In order to avoid distribution of fractional shares, GSCP 
retained 46 shares of Common Stock.                                             

Item 5 is hereby amended as follows:                                  

Item 5.  Interest in Securities of the Issuer.                        
------------------------------------                

As described in Item 4 above, on October 29, 1996, GSCP distributed   
shares of Common Stock owned by GSCP to its partners on a pro rata basis in     
accordance with GSCP's partnership agreement. As of November 5, 1996, GSCP      
beneficially owned and GS Advisors, L.P. may be deemed to beneficially own      
11,712 shares of Common Stock, representing less than 1% of the outstanding     
shares of Common Stock, including 11,666 shares of Common Stock that may be     
purchased pursuant to options that are currently exercisable or that may be     
exercised within 60 days. These options were issued by the Company to an        
officer of Goldman Sachs in his capacity as a director of the Company. This     
officer has an agreement with Goldman Sachs pursuant to which he holds the      
options for the benefit of GSCP, and such options may therefore be deemed to    
be beneficially owned by GSCP and GS Advisors, L.P. As of November 5, 1996,     
Goldman Sachs may be deemed to beneficially own a total of 2,249,073 shares of  
Common Stock (representing approximately 4.6% of the Common Stock reported to be
outstanding (as indicated in the Company's Form 10-K for the fiscal year ended  
June 30, 1996)), including 546,252 shares owned by the Other Limited            
Partnerships, 104 shares of Common Stock held by Goldman Sachs in connection    
with its ordinary course trading activities, 1,691,005 shares held in Managed   
Accounts and 11,712 shares beneficially owned by GSCP as described above. GS    
Group may be deemed to beneficially own the 2,249,073 shares of Common Stock    
beneficially owned by Goldman Sachs. As of November 5, 1996, GS Group also      
beneficially owned 1,227,482 shares of Common Stock it received in the          
Distribution and 833 shares of Common Stock that may be purchased pursuant to   
options that are currently exercisable. These options were issued by the Company
to an officer of Goldman Sachs in his capacity as a director of the Company.    
This officer has an agreement with GS Group pursuant to which he holds these    
options for the benefit of GS Group, and such options may therefore be deemed to
be beneficially owned by GS Group. Accordingly, as of November 5, 1996, GS Group
may be deemed to beneficially                                                   

SC 13D/A 9th Page of 17 TOC 1st Previous Next ↓Bottom Just 9th
own an aggregate of 3,477,388 shares of Common Stock (representing approximately
7.1% of the Common Stock reported to be outstanding (as indicated in the        
Company's Form 10-K for the fiscal year ended June 30, 1996)). Goldman Sachs and
GS Group each disclaims beneficial ownership of shares of Common Stock (i) owned
by the Other Limited Partnerships and GSCP to the extent of partnership         
interests in the Other Limited Partnerships and GSCP held by persons other than 
Goldman Sachs, GS Group or their affiliates and (ii) held in Managed Accounts.  
None of the Filing Persons and, to the knowledge of each of the Filing Persons, 
none of the Other Limited Partnerships that is not a Filing Person beneficially 
owns any shares of Common Stock other than as set forth herein.                 

     (b)  Each Filing Person has the power to vote or to direct the vote and
to dispose or to direct the disposition of shares of Common Stock beneficially  
owned by such Filing Person as indicated in pages 2 through 5 above.            

   (c) See Schedule IV hereto for transactions in the Common Stock which
have been effected since October 29, 1996, the date through which transactions  
were disclosed in Amendment No. 5 to this Schedule 13D.  All such transactions  
were effected in the ordinary course of business of Goldman Sachs. The          
transactions in Common Stock described in Schedule IV were effected on the      
NASDAQ National Market. The total consideration (exclusive of commissions) for  
shares of Common Stock purchased since October 29, 1996 is $9,700,098.          

   (e)  On October 29, 1996, each of GSCP, GS Advisors, L.P. and Goldman
Sachs ceased to be the beneficial owner of more than 5% of the Common Stock.    

SC 13D/A 10th Page of 17 TOC 1st Previous Next ↓Bottom Just 10th
SIGNATURE 
--------- 

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

             GS CAPITAL PARTNERS, L.P.
                               By:  GS Advisors, L.P., its general partner
                               BY:  GS Advisors, Inc., its general partner

                By: /s/  Richard A. Friedman
                                      ------------------------------------------
               Name:   Richard A. Friedman
     Title:  President

Dated:  November 6, 1996                                                        

SC 13D/A 11th Page of 17 TOC 1st Previous Next ↓Bottom Just 11th
SIGNATURE 
--------- 

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

     GS ADVISORS, L.P.
                               BY:  GS Advisors, Inc., its general partner

                By: /s/  Richard A. Friedman
                                      ------------------------------------------
               Name:   Richard A. Friedman
     Title:  President

Dated:  November 6, 1996                                                        

SC 13D/A 12th Page of 17 TOC 1st Previous Next ↓Bottom Just 12th
SIGNATURE 
--------- 

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

        GOLDMAN, SACHS & CO.

                By: /s/  Richard A. Friedman
                                      ------------------------------------------
               Name:   Richard A. Friedman
   Title:  Partner

Dated:  November 6, 1996                                                        

SC 13D/A 13th Page of 17 TOC 1st Previous Next ↓Bottom Just 13th
SIGNATURE 
--------- 

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and  
correct.                                                                        

                 THE GOLDMAN SACHS GROUP, L.P.

                By: /s/  Richard A. Friedman
                                      ------------------------------------------
               Name:   Richard A. Friedman
   Title:  Partner

Dated:  November 6, 1996                                                        

SC 13D/A 14th Page of 17 TOC 1st Previous Next ↓Bottom Just 14th
SCHEDULE IV 
----------- 

Quorum Health Group, Inc. 
Cusip: 749084-10-9  

                                                                [Download Table]

Reference No.  Purchase        Sale       Price      Td Date    Sttle. Date
                                                                           
1031-143032-12                 9,190      26 7/8   31-Oct-96     5-Nov-96  
1030-016783-13                 2,500      27 1/4   30-Oct-96     4-Nov-96  
1030-016784-13                 7,500      27 1/4   30-Oct-96     4-Nov-96  
1030-017047-13      2,976                 27 5/8   30-Oct-96     4-Nov-96  
1030-017048-13      7,000                 27 1/2   30-Oct-96     4-Nov-96  
1030-017049-13      1,000                 27 3/8   30-Oct-96     4-Nov-96  
1030-017050-13      1,000                 27 1/4   30-Oct-96     4-Nov-96  
1030-017051-13     11,000                     27   30-Oct-96     4-Nov-96  
1030-017134-13      3,785                 27 1/2   30-Oct-96     4-Nov-96  
1030-017135-13      1,000                 27 3/8   30-Oct-96     4-Nov-96  
1030-017136-13      1,000                 27 1/4   30-Oct-96     4-Nov-96  
1030-017137-13      8,000                     27   30-Oct-96     4-Nov-96  
1030-017151-13     22,976               27  1/16   30-Oct-96     4-Nov-96  
1030-017324-13                 2,500      27 1/4   30-Oct-96     4-Nov-96  
1030-020461-12      1,000                 27 3/4   30-Oct-96     4-Nov-96  
1030-021971-12                   700      27 3/4   30-Oct-96     4-Nov-96  
1030-021972-12                 2,500      27 3/4   30-Oct-96     4-Nov-96  
1030-021984-12                 1,000      27 3/4   30-Oct-96     4-Nov-96  
1030-021989-12                 1,000      27 3/4   30-Oct-96     4-Nov-96  
1030-022126-12                 5,000      27 3/4   30-Oct-96     4-Nov-96  
1030-022376-12                 3,500      27 5/8   30-Oct-96     4-Nov-96  
1030-022385-12                 1,000      27 5/8   30-Oct-96     4-Nov-96  
1030-022392-12                 1,000      27 5/8   30-Oct-96     4-Nov-96  
1030-022417-12                 5,000      27 1/2   30-Oct-96     4-Nov-96  
1030-022423-12                 1,000      27 1/2   30-Oct-96     4-Nov-96  
1030-022431-12                 1,000      27 1/2   30-Oct-96     4-Nov-96  
1030-022432-12                 1,000      27 1/2   30-Oct-96     4-Nov-96  
1030-022507-12                 1,000      27 3/8   30-Oct-96     4-Nov-96  
1030-022514-12                 1,000      27 1/4   30-Oct-96     4-Nov-96  
1030-022519-12                 5,000      27 1/4   30-Oct-96     4-Nov-96  
1030-022534-12                 1,000      27 1/4   30-Oct-96     4-Nov-96  
1030-022538-12                 1,000      27 1/4   30-Oct-96     4-Nov-96  
1030-022741-12                 1,000      27 1/4   30-Oct-96     4-Nov-96  
1030-022862-12                10,000    27  3/16   30-Oct-96     4-Nov-96  
1030-022965-12                 5,000    27  3/16   30-Oct-96     4-Nov-96  
1030-023527-12                 1,000    27  3/16   30-Oct-96     4-Nov-96  
1030-023530-12                 3,000    27  3/16   30-Oct-96     4-Nov-96  
1030-024128-12                 1,000      27 1/4   30-Oct-96     4-Nov-96  
1030-100787-13                50,000      27 1/4   30-Oct-96     4-Nov-96  
1030-112522-13     11,488                 27 1/8   30-Oct-96     4-Nov-96  
1030-260588-13      6,892                27  1/8   30-Oct-96     4-Nov-96  
1030-270621-13     10,000                 27.438   30-Oct-96     4-Nov-96  
1030-300784-13      1,000               27  5/16   30-Oct-96     4-Nov-96  
1030-300785-13      1,000               27  3/16   30-Oct-96     4-Nov-96  
1030-300786-13      2,595               26 15/16   30-Oct-96     4-Nov-96  

Page 1 of 4 

SC 13D/A 15th Page of 17 TOC 1st Previous Next ↓Bottom Just 15th
Quorum Health Group, Inc. 
Cusip: 749084-10-9  

                                                                [Download Table]

Reference No.  Purchase        Sale       Price      Td Date    Sttle. Date
                                                                           
1031-016610-13                 2,500      27 1/4   31-Oct-96     5-Nov-96  
1031-016611-13                 1,000      27 1/4   31-Oct-96     5-Nov-96  
1031-016612-13                 1,000      27 1/4   31-Oct-96     5-Nov-96  
1031-016613-13                 1,000      27 1/4   31-Oct-96     5-Nov-96  
1031-016614-13                 1,000      27 1/4   31-Oct-96     5-Nov-96  
1031-016615-13                 1,000      27 1/4   31-Oct-96     5-Nov-96  
1031-016819-13                   308      27.455   31-Oct-96     5-Nov-96  
1031-021311-12                 5,000      27 1/8   31-Oct-96     5-Nov-96  
1031-023823-12      1,200                 26 7/8   31-Oct-96     5-Nov-96  
1031-024131-12      1,300                 26 7/8   31-Oct-96     5-Nov-96  
1031-024136-12      2,000                 26 7/8   31-Oct-96     5-Nov-96  
1031-024494-12      2,000                 26 7/8   31-Oct-96     5-Nov-96  
1031-025529-12      1,400                     27   31-Oct-96     5-Nov-96  
1031-025536-12      1,000                     27   31-Oct-96     5-Nov-96  
1031-105500-13      1,000                 27 1/8   31-Oct-96     5-Nov-96  
1031-105501-13     22,500                 27 1/8   31-Oct-96     5-Nov-96  
1031-105502-13      1,500                 27 1/8   31-Oct-96     5-Nov-96  
1031-105529-13                10,000      26 7/8   31-Oct-96     5-Nov-96  
1031-120041-13      9,190               27  3/16   31-Oct-96     5-Nov-96  
1031-143032-13      9,190                 26 7/8   31-Oct-96     5-Nov-96  
1031-206240-13                 8,000      26 7/8   31-Oct-96     5-Nov-96  
1031-206241-13                   200      26 7/8   31-Oct-96     5-Nov-96  
1031-206242-13                   500      26 7/8   31-Oct-96     5-Nov-96  
1031-206243-13                 1,300      26 7/8   31-Oct-96     5-Nov-96  
1031-206594-13      5,000                 27 1/8   31-Oct-96     5-Nov-96  
1031-206633-13                 1,500      26 7/8   31-Oct-96     5-Nov-96  
1031-206634-13                 1,900      26 7/8   31-Oct-96     5-Nov-96  
8031-334104-13      1,488                 27 1/8   31-Oct-96     5-Nov-96  
1101-001145-13                 8,000      26 7/8    1-Nov-96     6-Nov-96  
1101-001146-13                 1,000      26 7/8    1-Nov-96     6-Nov-96  
1101-001147-13                 1,000      26 7/8    1-Nov-96     6-Nov-96  
1101-001148-13                   500      26 7/8    1-Nov-96     6-Nov-96  
1101-022847-12      5,000                 26 3/4    1-Nov-96     6-Nov-96  
1101-022848-12      1,000                 26 3/4    1-Nov-96     6-Nov-96  
1101-022898-12                 1,000      26 3/8    1-Nov-96     6-Nov-96  
1101-022983-12        800                 26 1/4    1-Nov-96     6-Nov-96  
1101-023171-12      1,500                 26 1/8    1-Nov-96     6-Nov-96  
1101-023570-12      5,000                 26 1/4    1-Nov-96     6-Nov-96  
1101-023591-12      5,000                 26 1/4    1-Nov-96     6-Nov-96  
1101-025320-12        600                 26 1/4    1-Nov-96     6-Nov-96  
1101-025321-12        500               26  5/16    1-Nov-96     6-Nov-96  
1101-025328-12      1,000                 26 3/8    1-Nov-96     6-Nov-96  
1101-025378-12      1,000                 26 1/2    1-Nov-96     6-Nov-96  
1101-025472-12        400                 26 1/2    1-Nov-96     6-Nov-96  
1101-105665-13                77,500     26.6008    1-Nov-96     6-Nov-96  
1101-110299-13      6,600                 26 1/2    1-Nov-96     6-Nov-96  
1101-111074-13                12,000      26 1/2    1-Nov-96     6-Nov-96  
1101-190395-13                22,100      26 3/8    1-Nov-96     6-Nov-96  
1101-190396-13                   600      26 3/8    1-Nov-96     6-Nov-96  
1101-190397-13                 1,400      26 3/8    1-Nov-96     6-Nov-96  

Page 2 of 4 

SC 13D/A 16th Page of 17 TOC 1st Previous Next ↓Bottom Just 16th
Quorum Health Group, Inc. 
Cusip: 749084-10-9  

                                                                [Download Table]

Reference No.  Purchase        Sale       Price      Td Date    Sttle. Date
                                                                           
1101-190398-13                 3,400      26 3/8    1-Nov-96     6-Nov-96  
1101-190519-13      5,000                 26 3/4    1-Nov-96     6-Nov-96  
1101-190606-13     10,000                 26 1/4    1-Nov-96     6-Nov-96  
1101-266116-13                 2,000      26 7/8    1-Nov-96     6-Nov-96  
1101-274274-13     40,000                 26 1/2    1-Nov-96     6-Nov-96  
1101-274780-13     17,100                 26 1/4    1-Nov-96     6-Nov-96  
1101-280432-13      9,190                 26 5/8    1-Nov-96     6-Nov-96  
1101-300876-13     13,890                 26 3/4    1-Nov-96     6-Nov-96  
1104-022864-12      1,000                 26 3/8    4-Nov-96     7-Nov-96  
1104-022865-12      1,000                 26 3/8    4-Nov-96     7-Nov-96  
1104-023924-12      1,532                 26 1/4    4-Nov-96     7-Nov-96  
1104-023928-12                 1,000      26 5/8    4-Nov-96     7-Nov-96  
1104-023929-12                 1,000      26 5/8    4-Nov-96     7-Nov-96  
1104-023961-12                 1,000      26 5/8    4-Nov-96     7-Nov-96  
1104-024227-12                 1,000      26 1/2    4-Nov-96     7-Nov-96  
1104-024233-12                 1,000      26 1/2    4-Nov-96     7-Nov-96  
1104-024374-12      1,000                     26    4-Nov-96     7-Nov-96  
1104-024441-12                 3,000    26  9/16    4-Nov-96     7-Nov-96  
1104-024446-12                 1,000    26  9/16    4-Nov-96     7-Nov-96  
1104-024448-12                   700    26  9/16    4-Nov-96     7-Nov-96  
1104-105231-13                 7,300      26 1/2    4-Nov-96     7-Nov-96  
1104-105232-13                 2,800      26 1/2    4-Nov-96     7-Nov-96  
1104-105233-13                 1,000      26 1/2    4-Nov-96     7-Nov-96  
1104-105460-13                25,000      26 1/4    4-Nov-96     7-Nov-96  
1104-190220-13                10,000      26 3/8    4-Nov-96     7-Nov-96  
1104-190221-13                   700      26 3/8    4-Nov-96     7-Nov-96  
1104-190222-13                   300      26 3/8    4-Nov-96     7-Nov-96  
1104-190223-13                 1,500      26 3/8    4-Nov-96     7-Nov-96  
1104-266068-13      1,700                 26 1/4    4-Nov-96     7-Nov-96  
1104-274203-13     30,000                 26.292    4-Nov-96     7-Nov-96  
1104-274207-13      5,000                 26 1/2    4-Nov-96     7-Nov-96  
1104-304053-13     10,000                 26 1/2    4-Nov-96     7-Nov-96  
1105-334016-13      6,000                     26    4-Nov-96     7-Nov-96  
1105-334017-13      5,500                 26 1/8    4-Nov-96     7-Nov-96  
1105-334018-13      5,500                 26 3/8    4-Nov-96     7-Nov-96  
1105-334019-13      5,976                 26 3/8    4-Nov-96     7-Nov-96  
1105-022356-12                 2,500      25 7/8    5-Nov-96     8-Nov-96  
1105-022380-12                   500      25 7/8    5-Nov-96     8-Nov-96  
1105-022381-12                 2,500      25 7/8    5-Nov-96     8-Nov-96  
1105-022426-12                 2,500      25 7/8    5-Nov-96     8-Nov-96  
1105-022637-12                   600      25 7/8    5-Nov-96     8-Nov-96  
1105-022904-12      1,000                 25 7/8    5-Nov-96     8-Nov-96  
1105-023468-12                 2,000          26    5-Nov-96     8-Nov-96  
1105-023469-12                   500          26    5-Nov-96     8-Nov-96  
1105-023472-12                 2,000          26    5-Nov-96     8-Nov-96  
1105-023536-12                 1,000          26    5-Nov-96     8-Nov-96  
1105-023537-12                   800          26    5-Nov-96     8-Nov-96  
1105-025246-12                 3,500          26    5-Nov-96     8-Nov-96  
1105-025354-12                 3,500          26    5-Nov-96     8-Nov-96  
1105-190803-13      2,500                 25 3/4    5-Nov-96     8-Nov-96  

Page 3 of 4 

SC 13D/A Last Page of 17 TOC 1st Previous Next ↓Bottom Just 17th
Quorum Health Group, Inc. 
Cusip: 749084-10-9  

                                                                [Download Table]

Reference No.  Purchase        Sale       Price      Td Date    Sttle. Date
                                                                           
1105-190804-13      2,500                 25 7/8    5-Nov-96     8-Nov-96  
1105-190805-13      2,500                     26    5-Nov-96     8-Nov-96  
1105-286081-13      4,595                 25 5/8    5-Nov-96     8-Nov-96  

Page 4 of 4

SC 13D/A	1st Page of 17	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13D/A	2nd Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13D/A	3rd Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13D/A	4th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13D/A	5th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13D/A	6th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13D/A	7th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13D/A	8th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13D/A	9th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 9th

SC 13D/A	10th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 10th

SC 13D/A	11th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 11th

SC 13D/A	12th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 12th

SC 13D/A	13th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 13th

SC 13D/A	14th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 14th

SC 13D/A	15th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 15th

SC 13D/A	16th Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 16th

SC 13D/A	Last Page of 17	TOC	1st	Previous	Next	↓Bottom	Just 17th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13D/A’ Filing	Date	First	Last	Other Filings

Filed on:	11/7/96
	11/6/96	10	13
	11/5/96	8
	10/30/96	6		SC 13D/A
	10/29/96	1	9
	6/30/96	8	9	10-K
				List all Filings

↑Top

Filing Submission 0000950130-96-004227 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Goldman Sachs Group Inc, et al. – ‘SC 13D/A’ on 11/7/96 re: Quorum Health Group Inc

As of: Thursday, 11/7/96 · Accession #: 950130-96-4227 · File #: 5-43277

Previous ‘SC 13D’: ‘SC 13D/A’ on 10/30/96 · Next: ‘SC 13D/A’ on 11/25/96 · Latest: ‘SC 13D’ on 10/8/99

Amendment to General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents